TY - JOUR
T1 - Geographical migration and fitness dynamics of Streptococcus pneumoniae
AU - The Global Pneumococcal Sequencing Consortium
AU - Belman, Sophie
AU - Lefrancq, Noémie
AU - Nzenze, Susan
AU - Downs, Sarah
AU - du Plessis, Mignon
AU - Lo, Stephanie W.
AU - McGee, Lesley
AU - Madhi, Shabir A.
AU - von Gottberg, Anne
AU - Bentley, Stephen D.
AU - Salje, Henrik
AU - Corso, Alejandra
AU - Gagetti, Paula
AU - Brooks, Abdullah W.
AU - Hasanuzzaman, Md
AU - Saha, Samir K.
AU - Saha, Senjuti
AU - Davydov, Alexander
AU - Titov, Leonid
AU - Almeida, Samanta Cristine Grassi
AU - Turner, Paul
AU - Zhao, Chunjiang
AU - Wang, Hui
AU - Ip, Margaret
AU - Ho, Pak Leung
AU - Law, Pierra
AU - Keenan, Jeremy D.
AU - Cohen, Robert
AU - Varon, Emmanuelle
AU - Sampane-Donkor, Eric
AU - Veeraraghavan, Balaji
AU - Nagaraj, Geetha
AU - Ravikumar, K. L.
AU - Yuvaraj, J.
AU - Shamanna Noga, Varun
AU - Benisty, Rachel
AU - Dagan, Ron
AU - Bigogo, Godfrey
AU - Verani, Jennifer
AU - Kiran, Anmol
AU - Everett, Dean B.
AU - Cornick, Jennifer
AU - Alaerts, Maaike
AU - Sekaran, Shamala Devi
AU - Clarke, Stuart C.
AU - Moiane, Benild
AU - Sigauque, Betuel
AU - Mucavele, Helio
AU - Pollard, Andrew J.
AU - Kandasamy, Rama
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/7/11
Y1 - 2024/7/11
N2 - Streptococcus pneumoniae is a leading cause of pneumonia and meningitis worldwide. Many different serotypes co-circulate endemically in any one location1,2. The extent and mechanisms of spread and vaccine-driven changes in fitness and antimicrobial resistance remain largely unquantified. Here using geolocated genome sequences from South Africa (n = 6,910, collected from 2000 to 2014), we developed models to reconstruct spread, pairing detailed human mobility data and genomic data. Separately, we estimated the population-level changes in fitness of strains that are included (vaccine type (VT)) and not included (non-vaccine type (NVT)) in pneumococcal conjugate vaccines, first implemented in South Africa in 2009. Differences in strain fitness between those that are and are not resistant to penicillin were also evaluated. We found that pneumococci only become homogenously mixed across South Africa after 50 years of transmission, with the slow spread driven by the focal nature of human mobility. Furthermore, in the years following vaccine implementation, the relative fitness of NVT compared with VT strains increased (relative risk of 1.68; 95% confidence interval of 1.59–1.77), with an increasing proportion of these NVT strains becoming resistant to penicillin. Our findings point to highly entrenched, slow transmission and indicate that initial vaccine-linked decreases in antimicrobial resistance may be transient.
AB - Streptococcus pneumoniae is a leading cause of pneumonia and meningitis worldwide. Many different serotypes co-circulate endemically in any one location1,2. The extent and mechanisms of spread and vaccine-driven changes in fitness and antimicrobial resistance remain largely unquantified. Here using geolocated genome sequences from South Africa (n = 6,910, collected from 2000 to 2014), we developed models to reconstruct spread, pairing detailed human mobility data and genomic data. Separately, we estimated the population-level changes in fitness of strains that are included (vaccine type (VT)) and not included (non-vaccine type (NVT)) in pneumococcal conjugate vaccines, first implemented in South Africa in 2009. Differences in strain fitness between those that are and are not resistant to penicillin were also evaluated. We found that pneumococci only become homogenously mixed across South Africa after 50 years of transmission, with the slow spread driven by the focal nature of human mobility. Furthermore, in the years following vaccine implementation, the relative fitness of NVT compared with VT strains increased (relative risk of 1.68; 95% confidence interval of 1.59–1.77), with an increasing proportion of these NVT strains becoming resistant to penicillin. Our findings point to highly entrenched, slow transmission and indicate that initial vaccine-linked decreases in antimicrobial resistance may be transient.
UR - http://www.scopus.com/inward/record.url?scp=85197560021&partnerID=8YFLogxK
U2 - 10.1038/s41586-024-07626-3
DO - 10.1038/s41586-024-07626-3
M3 - Article
C2 - 38961295
AN - SCOPUS:85197560021
SN - 0028-0836
VL - 631
SP - 386
EP - 392
JO - Nature
JF - Nature
IS - 8020
ER -